Olympus Innovation Ventures

Overview

Olympus Innovation Ventures (OIV) is the corporate venture capital arm of Olympus Corporation, established to invest in early-stage companies that align with Olympus's growth objectives. OIV focuses on startups in the medical technology sector, particularly in areas such as gastrointestinal, urology, and respiratory solutions. The fund aims to enhance Olympus's market leadership by partnering with innovative entrepreneurs and gaining access to new technologies and market insights. The investment strategy of OIV is stage-agnostic, prioritizing early to growth-stage companies globally. The fund typically invests between $500,000 and $5 million in each portfolio company. In addition to capital, Olympus offers its clinical and technical expertise, access to healthcare professionals and hospitals, and the ability to launch and scale innovative solutions in the global market. Since its inception in October 2021, OIV has made several investments in areas such as AI workflow solutions and medical imaging agents for cancer detection. The fund continues to support Olympus's commitment to elevating unique capabilities and driving growth in the global MedTech ecosystem.

Investment Focus

• Innovative technologies in medical devices, diagnostics, and digital health
• Alignment with Olympus's growth objectives
• Early to growth-stage companies globally

Portfolio Companies